SILVER SPRING, Md., July 11, 2011 /PRNewswire-USNewswire/ -- Science, public health, and regulatory highlights from the U.S. Food and Drug Administration. Information in this document is designed for credentialed journalists. Release dates and times for items are current as of July 11, 2011.
(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)
FDA News & Notes does not contain any regulatory or enforcement actions due to legal limitations.
Events and Speeches for the Commissioner and FDA leadership:
Friday, 7/15 – Commissioner of Food and Drugs Margaret A. Hamburg is the featured speaker at The City Club of Cleveland's Friday Forum series. The forum format includes prepared remarks for about 30 minutes followed by questions posed by members of the audience. Reservations required for event. Live webcast. Noon, 850 Euclid Ave., The City Club Building, 2nd Floor, Cleveland.
Press Office Contact: Raymond Formanek Jr., 301-796-4677, [email protected]
Meetings, Workshops and Congressional Testimony:
Thursday, 7/14 –The Oncologic Drugs Advisory Committee discusses a biologics application for Adcetris (brentuximab vedotin) to treat relapsed or resistant to standard treatment Hodgkin's lymphoma during a morning session. In the afternoon, the advisory committee discusses a biologics application for Adcetris for treatment of relapsed or standard treatment resistant systemic anaplastic large cell lymphoma. Both applications submitted by Seattle Genetics. 8 a.m., 10903 New Hampshire Ave., Building 31, Room 1503, Silver Spring, Md.
Press Office Contact: Erica Jefferson, 301-796-4988, [email protected]
FDA Office of Public Affairs Contact Information:
Call or email FDA Office of Public Affairs, 301-796-4540, [email protected]
List of FDA press officers and beats
More Resources:
#
SOURCE U.S. Food and Drug Administration
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article